Reply  by Vlahakes, Gus J.
benefits: First, the filling of the LV cavity
during diastole will maintain RV geometry.
(This was indicted in the article by the
displacement of the septum with LV filling,
Figure 5). This more physiologic shape in
diastole may affect the compliance of the
right ventricle with subsequent beneficial
effects on wall tension and subendocardial
perfusion. Again, the use of the diastolic
pressure-volume curve may identify this.
Second, LV ejection will add pulsatility to
the systemic arterial supply, which may
allow greater perfusion at marginal pres-
sure gradients.
Mark H. Danton, MD
Cardiac Surgical Department
Royal Group of Hospitals
Belfast, Northern Ireland BT12 6BA,
United Kingdom
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Reply to the Editor:
My colleagues and I appreciate the ques-
tions raised by Danton in his letter to the
Editor. The relationship between maximum
right ventricular (RV) function and sys-
temic pressure was suggested in 1955 by
Peter Salisbury.1 On the basis of this early
study, we2 demonstrated that, at the onset
of RV failure, the RV free wall becomes
ischemic, and this ischemia and failure can
be reversed by raising systemic pressure.
Although we believed that the entire matter
was simply an issue of RV perfusion, ad-
ditional studies from our laboratory began
to cast doubt on this hypothesis. Page and
associates,3 using a model in which the
right coronary circulation perfuses only the
RV free wall, demonstrated that the maxi-
mal pressure developed by the right ventri-
cle is determined primarily by maximal
developed left ventricular (LV) pressure,
and not by right coronary perfusion pres-
sure. The issue of RV free wall versus left
heart contribution was further explored by
Damiano and colleagues4 in a model in
which the RV free wall was electrophysi-
ologically isolated from the rest of the
heart. They demonstrated two distinct con-
tributions to global RV function: one de-
rived from RV free wall contraction and
one derived from contraction of the left
side of the heart. On the basis of these
studies, we undertook the study recently
published by Klima and coworkers5 to in-
vestigate further the nature of left heart
contribution to RV function.
Putting together the findings of our re-
cent study with the prior work has led us to
conclude that approximately half of RV
function is derived from the contribution of
the free wall, which is dependent on perfu-
sion pressure, combined with a significant
contribution from the left side of the heart,
that is, via the interventricular septum. Fur-
thermore, in our study, even when no LV
preload was introduced into the left ventri-
cle, the ventricle still developed pressure
because of blood returning to the left side
of the heart through the thebesian vessels;
in our preparation, peak developed LV
pressure closely correlated with aortic pres-
sure, irrespective of left heart output. Al-
though we do not deny the role of RV free
wall ischemia in the pathogenesis of RV
failure, we do maintain that the process is
complex with multiple determinants.
Irrespective of mechanism, our study
supports the physiologic principle that de-
veloped LV pressure, and hence systemic
pressure, must be maintained when treating
patients with RV failure.
Gus J. Vlahakes, MD
Massachusetts General Hospital
55 Fruit St—BUL 119
Boston, MA 02114-2696
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Thymolipomas with myasthenia
gravis in Japan
To the Editor:
With great interest we read the article,
“Thymolipoma in Association With Myas-
thenia Gravis,” by Zambudio and col-
leagues.1 They reviewed 18 case reports
about thymolipoma with myasthenia gra-
vis, including 3 Japanese cases.
We also reviewed 14 case reports about
thymolipoma with myasthenia gravis in
1993.2 To our knowledge, there are 9 cases
in Japan, including our new case (Table
1).2-4 The patients comprised 2 men and 7
women, with a mean age of 50  14 years
(29-76 years). The mean thymolipoma
weight was 385  355 g (55-850 g).
Thymolipomas with myasthenia gravis ap-
pear in older patients and are smaller than
thymolipomas without myasthenia gravis
(mean age 34  18 years, mean weight
640  650 g) according our previous re-
view.5
As Zambudio and colleagues discussed
in their comment, we think the best current
surgical treatment for thymolipoma with
myasthenia gravis is extended thymecto-
my.2 We also think that extended thymec-
tomy is the preferable surgical treatment
for thymolipoma even without myasthenia
gravis, since patients with thymolipoma
may have a high titer of serum antiacetyl-
choline receptor antibodies.5
We thank Zambudio and colleagues for
calling attention to this subject.
Mitsuhiro Yamamura, MD, FICA
Takashi Miyamoto, MD, FICA
Hideki Yao, MD
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